PAUL R. FONTEYNE

Insider Reports History

Location
Boston, MA
Signature
/s/ David Watson, attorney-in-fact for Paul Fonteyne
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by PAUL R. FONTEYNE:

Company Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. Director Common Stock 30,666 $724,637 $23.63 01 Jan 2026 Direct
Apellis Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 14,684 $381,092 $66.30 01 Jan 2026 Direct
GELESIS HOLDINGS, INC. Director Common Stock 53,832 06 May 2022 Direct
Amylyx Pharmaceuticals, Inc. Director Stock Option (right to buy) 25,000 05 Jun 2025 Direct
COVETRUS, INC. Director Common Stock 0 $20.88 13 Oct 2022 Direct
COVETRUS, INC. Director Restricted Stock Units 0 13 Oct 2022 Direct

Insider Reports Filed by PAUL R. FONTEYNE

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APLS Apellis Pharmaceuticals, Inc. 01 Jan 2026 2 $0 4 Director 05 Jan 2026, 16:36
AMLX Amylyx Pharmaceuticals, Inc. 05 Jun 2025 1 $0 4 Director 09 Jun 2025, 16:12
APLS Apellis Pharmaceuticals, Inc. 01 Jan 2025 2 $0 4 Director 03 Jan 2025, 16:19
AMLX Amylyx Pharmaceuticals, Inc. 06 Jun 2024 1 $0 4 Director 07 Jun 2024, 16:52
APLS Apellis Pharmaceuticals, Inc. 01 Jan 2024 2 +$344,075 4 Director 02 Jan 2024, 16:13
AMLX Amylyx Pharmaceuticals, Inc. 08 Jun 2023 1 $0 4 Director 12 Jun 2023, 19:34
APLS Apellis Pharmaceuticals, Inc. 01 Jan 2023 2 $0 4 Director 04 Jan 2023, 16:31
/report/000175283622000143-fonteyne-paul-r-2022-10-13 COVETRUS, INC. 13 Oct 2022 2 $0 4 Director 13 Oct 2022, 11:03
/report/000175283622000098-fonteyne-paul-r-2022-07-01 COVETRUS, INC. 01 Jul 2022 2 $0 4 Director 06 Jul 2022, 16:06
AMLX Amylyx Pharmaceuticals, Inc. 09 Jun 2022 1 $0 4 Director 10 Jun 2022, 16:05
/report/000175283622000071-fonteyne-paul-r-2022-05-11 COVETRUS, INC. 11 May 2022 1 $0 4 Director 13 May 2022, 16:10
CPSR GELESIS HOLDINGS, INC. 06 May 2022 1 $0 4 Director 09 May 2022, 16:17
CPSR GELESIS HOLDINGS, INC. 13 Jan 2022 0 $0 3 Director 24 Jan 2022, 15:39
AMLX Amylyx Pharmaceuticals, Inc. 06 Jan 2022 2 +$74,993 4 Director 10 Jan 2022, 19:37
AMLX Amylyx Pharmaceuticals, Inc. 06 Jan 2022 0 $0 3 Director 06 Jan 2022, 16:06
APLS Apellis Pharmaceuticals, Inc. 01 Jan 2022 2 $0 4 Director 04 Jan 2022, 20:28
/report/000175283621000236-fonteyne-paul-r-2021-08-10 COVETRUS, INC. 10 Aug 2021 1 +$116,200 4 Director 11 Aug 2021, 16:09
/report/000175283621000213-fonteyne-paul-r-2021-07-01 COVETRUS, INC. 01 Jul 2021 1 $0 4 Director 06 Jul 2021, 16:03
/report/000175283621000212-fonteyne-paul-r-2021-07-01 COVETRUS, INC. 01 Jul 2021 0 $0 3 Director 06 Jul 2021, 16:01